Clinical and biological underpinnings of longitudinal atrophy pattern progression in Alzheimer's disease

Pilar M Ferraro1, Laura Filippi1, Marta Ponzano2

  • 1IRCCS Ospedale Policlinico San Martino, Genoa, Italy.

PubMed
Abstract

Insights

Alzheimer's disease subtypes can change over time. Clinical and cognitive factors, not biomarkers, predict these shifts, suggesting a common progression pathway for different AD forms.

Area of Science:

  • Neurology
  • Radiology
  • Biomedical Imaging

Background:

  • Four Alzheimer's disease (AD) subtypes identified via MRI: hippocampal sparing (HpSp), typical AD (tAD), limbic predominant (Lp), and minimal atrophy (MinAtr).
  • Limited understanding of longitudinal changes and clinical/biological differences among these AD subtypes.

Purpose of the Study:

  • Investigate the clinical and biological factors influencing longitudinal atrophy pattern progression in Alzheimer's disease.
  • Determine predictors for patients switching between MRI-defined AD subtypes.

Main Methods:

  • Analyzed 251 Alzheimer's Disease Neuroimaging Initiative (ADNI) participants across disease stages.
  • Classified baseline MRI atrophy subtypes using cortical:hippocampal volume ratios.
  • Tracked longitudinal scan data to identify "switching" vs. "stable" patients; logistic regression used for predictor analysis.

Main Results:

  • Significant subtype switching observed: 40% Lp, 26% HpSp, 35% MinAtr.
  • Typical AD (tAD) was the primary destination subtype for most switching cases.
  • Baseline differences in clinical, cognitive, and biomarker data existed across subtypes; only clinical and cognitive variables predicted switching.

Conclusions:

  • Suggests convergent disease progression pathways across typical and atypical Alzheimer's disease subtypes in a subset of patients.
  • Emphasizes the value of deep-phenotyping for understanding Alzheimer's disease heterogeneity.

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
448
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
165
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
482
Aging01:26

Aging

Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
37
Long-term Depression01:03

Long-term Depression

Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over...
2.5K